Standard Life Aberdeen »

Alx Oncology Hldgs shares owned by Standard Life Aberdeen

Quarter-by-quarter ownership of Alx Oncology Hldgs (ALXO) shares owned by Standard Life Aberdeen from 13F filings

Historical chart of Standard Life Aberdeen investment in Alx Oncology Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Alx Oncology Hldgs held by Standard Life Aberdeen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alx Oncology Hldgs by Standard Life Aberdeen

Quarter filed Position value Share count Share price at filing
2023-12-31 $986k 66k 14.89

More positions owned by Standard Life Aberdeen

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Merck & Co (MRK)
Meta Platforms Cl A (META)
Mastercard Incorporated Cl A (MA)
Broadcom (AVGO)
Procter & Gamble Company (PG)
JPMorgan Chase & Co. (JPM)

View all positions for Standard Life Aberdeen

Top funds holding Alx Oncology Hldgs

venBio Partners
Vivo Capital
Redmile Group
Cormorant Asset Management
OrbiMed Advisors
Vanguard Group
Citadel Advisors
Point72 Asset Management
T. Rowe Price Associates
Charles Schwab Investment Management
Federated Investors
Dimensional Fund Advisors
Schonfeld Strategic Advisors
Thomas Stevens, CFA"
Goldman Sachs Group

View all funds holding Alx Oncology Hldgs